Mark Chin, Director at Iterum Therapeutics plc (ITRM), bought 586,327 shares at $13.00 ($4.4M) on 2018-05-30, disclosed to the SEC on 2018-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 248,721 | $0 | 0.0% |
| 2 | $13.00 | 337,606 | $4.4M | 100.0% |
| Total | $7.49 avg | 586,327 | $4.4M | 100% |
| Filing → |
| IMRA | BUY | 2021-07-28 | $8.0M | — | Filing → |
| IMRA | BUY | 2020-03-16 | $3.0M | — | Filing → |
| HARP | SELL | 2019-12-17 | $1.2M | — | Filing → |